Andrew M. Erickson

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Comparable recurrence risk for MRI-detected Gleason Grade Group (GG) 2 and systematic biopsy-detected GG1 prostate cancer.

Comparable recurrence risk for MRI-detected Gleason Grade Group (GG) 2 and systematic biopsy-detected GG1 prostate cancer.

Journal: BJU international
Published: December 15, 2025

Altered Glycosylation of PSA in Prostate Cancer Tissue.

Altered Glycosylation of PSA in Prostate Cancer Tissue.

Journal: The Prostate
Published: May 20, 2025

Clonal phylogenies inferred from bulk, single cell, and spatial transcriptomic analysis of epithelial cancers.

Clonal phylogenies inferred from bulk, single cell, and spatial transcriptomic analysis of epithelial cancers.

Journal: PloS one
Published: June 07, 2024

Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer.

Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer.

Journal: Nature communications
Published: June 03, 2024

ScType enables fast and accurate cell type identification from spatial transcriptomics data.

ScType enables fast and accurate cell type identification from spatial transcriptomics data.

Journal: Bioinformatics (Oxford, England)
Published: February 20, 2024

MRI-Targeted Prostate Biopsy Introduces Grade Inflation and Overtreatment.

MRI-Targeted Prostate Biopsy Introduces Grade Inflation and Overtreatment.

Journal: medRxiv : the preprint server for health sciences
Published: January 23, 2024

Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.

Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.

Journal: Molecular cancer
Published: June 12, 2023

Prognostic impact of kallikrein-related peptidase transcript levels in prostate cancer.

Prognostic impact of kallikrein-related peptidase transcript levels in prostate cancer.

Journal: International journal of cancer
Published: September 06, 2022

Infectious complications after transrectal MRI-targeted and systematic prostate biopsy.

Infectious complications after transrectal MRI-targeted and systematic prostate biopsy.

Journal: World journal of urology
Published: May 02, 2022

PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers.

PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers.

Journal: Molecular oncology
Published: March 14, 2022

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression.

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression.

Journal: Cancers
Published: November 25, 2021

Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer.

Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer.

Journal: The Prostate
Published: October 22, 2021
Showing 1-12 of 37

Last Updated: 09/26/2026